ERBB2 and breast carcinoma: This is consistent with the fact that phosphatidylinositol-3 kinase/mechanistic target of rapamycin (PI3K/mTOR) signaling mediates HER2 downstream signaling and is implicated in the pathogenesis of HER2-overexpressing breast cancers.